Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assess the Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus Among Individuals With High Cardiometabolic Risk

NCT05749874 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT05749874
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05749874 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assess the Effects of Berberine on Preventing Cardiovascular Disease and Diabetes Mellitus Among Individuals With High Cardiometabolic Risk
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Phase 4
Overall status
Active, not recruiting
Start date
October 31, 2023
Completion date
December 31, 2026
Enrollment
2,024 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal obesity, atherosclerotic cardiovascular disease, dyslipidemias, hypertension, prediabetes